News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current IVX market cap is 899.43M. The company's latest EPS is AUD -0.0009 and P/E is -155.56.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 3.55M | 2.42M | 3.37M | 4.11M | 3.74M |
| Operating Income | -959k | -1.48M | -2.24M | -1.65M | -1.69M |
| Net Income | -954k | -1.48M | -2.24M | -1.62M | -5.63M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 5.76M | 5.64M | 20.04M | 19.05M | 15.45M |
| Total Liabilities | 327k | 851k | 462k | 651k | 1.01M |
| Total Equity | 5.43M | 4.79M | 19.58M | 18.4M | 14.44M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -152k | 418k | -1.11M | -1.81M | -2.4M |
| Investing | N/A | N/A | -7.25M | -2.58M | -900k |
| Financing | N/A | N/A | 15.8M | N/A | N/A |
| Market Cap | 899.43M |
| Price to Earnings Ratio | -155.56 |
| Price to Sales Ratio | 233.33 |
| Price to Cash Ratio | 1.4k |
| Price to Book Ratio | 62.3 |
| Dividend Yield | - |
| Shares Outstanding | 6.42B |
| Average Volume (1 week) | 91.66k |
| Average Volume (1 Month) | 115.45k |
| 52 Week Change | 2,700.00% |
| 52 Week High | 0.43 |
| 52 Week Low | 0.002 |
| Spread (Intraday) | 0.01 (3.45%) |
| Company Name | Invion Ltd |
| Address |
level 4 melbourne, victoria 3205 |
| Website | https://inviongroup.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
